Sex and rat strain determine sensitivity to κ opioid-induced antinociception

Psychopharmacology

Volumn 160, Issue 2, 2002, Pages 170-181

  Barrett, Andrew C ^a   Cook, Charles D ^b   Terner, Jolan M ^a   Roach, Emily L ^a   Syvanthong, Chockeo ^a   Picker, Mitchell J ^a  

^a University of North Carolina at Chapel Hill   (United States)

^b VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

Antinociception; Efficacy; Opioid; Sex difference; Strain

Indexed keywords

3,4 DICHLORO N METHYL N [2 (1 PYRROLIDINYL)CYCLOHEXYL]BENZENEACETAMIDE; BREMAZOCINE; ENADOLINE; HOT WATER; KAPPA OPIATE RECEPTOR AGONIST; MU OPIATE RECEPTOR AGONIST; NALORPHINE; SPIRADOLINE;

ANIMAL EXPERIMENT; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG ANTAGONISM; DRUG EFFECT; DRUG EFFICACY; DRUG POTENCY; DRUG SENSITIVITY; FEMALE; MALE; NOCICEPTIVE STIMULATION; NONHUMAN; PRIORITY JOURNAL; RAT; RAT STRAIN; SEX DIFFERENCE; STRAIN DIFFERENCE; THERMAL STIMULATION; WITHDRAWAL REFLEX;

3,4-DICHLORO-N-METHYL-N-(2-(1-PYRROLIDINYL)-CYCLOHEXYL)-BENZENEACETAMIDE, (TRANS)-ISOMER; ANALGESICS; ANIMALS; BENZOFURANS; BENZOMORPHANS; FEMALE; MALE; NALORPHINE; NARCOTICS; PYRROLIDINES; RATS; RATS, INBRED F344; RATS, INBRED LEW; RATS, INBRED STRAINS; RATS, SPRAGUE-DAWLEY; RECEPTORS, OPIOID, KAPPA; SEX CHARACTERISTICS;

EID: 0036196396     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00213-001-0949-2     Document Type: Article

References (43)

1. Importance of sex and relative efficacy at the μ opioid receptor in the development of tolerance and cross-tolerance to the antinociceptive effects of opioids
2. Sex differences in opioid antinociception
3. Selective breeding for levorphanol-induced antinociception on the hot-plate assay: Commonalities in mechanism of action with morphine, pentazocine, ethylketocyclazocine, U50,488H and clonidine in mice
4. 35S]GTPγS binding and cyclic AMP production
5. Sex differences and phases of the estrous cycle alter the response of spinal cord dynorphin neurons to peripheral inflammation and hyperalgesia
6. Kappa opioid antagonist effects of systemically administered nor-binaltorphimine in a thermal antinociception assay in rhesus monkeys
7. Kappa-opioid receptor binding populations in rhesus monkey brain: Relationship to an assay of thermal antinociception
8. Kappa opioid receptors in rat spinal cord vary across the estrous cycle
9. Gender-related differences in the antinociceptive properties of morphine
10. Sex-related differences in morphine's antinociceptive activity: Relationship to serum and brain morphine concentrations
11. Sex-related differences in the antinociceptive effects of opioids: Importance of rat genotype, nociceptive stimulus intensity and efficacy at the μ opioid receptor
12. 3/2 agonists on kappa opioid-induced antinociception and diuresis in the rat
13. Sex differences in opioid anti-nociception: κ and "mixed action" agonists
14. Sex differences in discriminative stimulus and diuretic effects of the κ opioid agonist U69,593 in the rat
15. Butorphanol, levallorphan, nalbuphine and nalorphine as antagonists in the squirrel monkey
16. Genetic variance in nociception and its relationship to the potency of morphine-induced analgesia in thermal and chemical tests
17. Comparison of kappa opioids in rhesus monkeys: Behavioral effects and receptor binding affinities
18. Kappa-opioids produce significantly greater analgesia in women than men
19. The kappa opioid nalbuphine produces gender- and dose-dependent analgesia and antianalgesia in patients with postoperative pain
20. Differences in the antinociceptive effects ofalpha-2 adrenoreceptor agonists in two substrains of Sprague-Dawley rats
21. CI-977, a novel and selective agonist for the κ-opioid receptor
22. Sex and day-night differences in opiate-induced responses of insular wild deer mice, peromyscus maniculatus triangularis
23. Roles of gender, gonadectomy and estrous phase in the analgesic effects of intracerebroventricular morphine
24. Sex differences in supraspinal morphine analgesia are dependent on genotype
25. Evidence that nalorphine, butorphanol and oxilorphan are partial agonists at a kappa-opioid receptor
26. Interactions between sex and genotype in the mediation and modulation of nociception in rodents
27. One or two genetic loci mediate high opiate analgesia in selectively bred mice
28. Differential genetic mediation of sensitivity to morphine in genetic models of opiate antinociception: Influence of nociceptive assay
29. 2-opioid receptors
30. Sex differences in thermal nociception and morphine antinociception in rodents depend on genotype
31. Opioid antinociception in ovariectomized monkeys: Comparison with antinociception in males and effects of estradiol replacement
32. Effects of gonadal steroid hormone treatment on opioid antinociception in ovariectomized rhesus monkeys
33. Comparison of the antinociceptive effects induced by kappa opioid agonists in male and female mice
34. Genetic influences in opioid analgesic sensitivity in mice
35. Antinociceptive and response rate-altering effects of kappa opioid agonists, spiradoline, enadoline and U69,593, alone and in combination with opioid antagonists in squirrel monkeys
36. Sex differences in morphine analgesia
37. Differential sensitivity of antinociceptive tests to opioid agonists and partial agonists
38. Antinociceptive effects of opioids following acute and chronic administration of butorphanol: Influence of stimulus intensity and relative efficacy at the mu receptor
39. Brainstem pain modulating circuitry is sexually dimorphic with respect to mu and kappa opioid receptor function
40. κ-Opioid receptor-mediated analgesia: Hotplate temperature and sex differences
41. 35S]GTPγS binding to membranes: Determination of potencies and efficacies of ligands